Final barrier to clear for new bladder cancer tests
Big milestone for company. With special audio feature.
Pacific Edge [NZX: PEB] says it’s confident the company’s bladder cancer test will pass Canterbury District Health Board’s final hurdle with flying colours.
Yesterday, the company’s shares jumped more than 10% on the news that the Canterbury DHB is about to become the first health authority to
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Jenny Ruth
Thu, 10 Mar 2016
Thu, 10 Mar 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Related News
Related News
Final barrier to clear for new bladder cancer tests
56322